NESTROFT test is used in the screening of
**Core Concept**
The NESTROFT test is a screening method used for the detection of beta-thalassemia trait, a genetic disorder affecting hemoglobin production. It involves the detection of fetal hemoglobin in the peripheral blood of individuals suspected to have the trait.
**Why the Correct Answer is Right**
The NESTROFT test is based on the principle of acid elution of hemoglobin, where fetal hemoglobin is more resistant to acid elution compared to adult hemoglobin. This test involves the application of an acid solution to the blood sample, and the presence of fetal hemoglobin is indicated by the retention of hemoglobin on the filter paper. The test is a simple and cost-effective method for screening beta-thalassemia trait, particularly in areas where more sophisticated diagnostic tools are not readily available.
**Why Each Wrong Option is Incorrect**
* **Option A:** This option is not relevant as the NESTROFT test is specifically designed for the detection of beta-thalassemia trait.
* **Option B:** This option is incorrect as the NESTROFT test is not used for the screening of other hemoglobinopathies such as sickle cell disease.
* **Option C:** This option is not relevant as the NESTROFT test is not used for the screening of other genetic disorders.
**Clinical Pearl / High-Yield Fact**
The NESTROFT test is a useful screening tool for beta-thalassemia trait, particularly in areas where more sophisticated diagnostic tools are not readily available. However, it is essential to note that a positive result may require further confirmation through more specific diagnostic tests.
**Correct Answer: B. NESTROFT test is used in the screening of beta-thalassemia trait.**